15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism
JACC: Cardiovascular Interventions · 2025-06 · 18 (12) · 1526-1537
DOI: 10.1016/j.jcin.2025.04.041 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-06. Verfasst von Carlo Gaspardone und 35 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Foramen Ovale, Patent, Cardiac Catheterization, Embolism, Paradoxical, Ischemic Stroke. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Transcatheter patent foramen ovale (PFO) closure has become the gold-standard treatment for patients with cryptogenic embolism and PFO, but long-term outcomes data are limited. OBJECTIVES: The aim of this study was to report the extended clinical outcomes of patients who underwent transcatheter PFO closure for cryptogenic embolism. METHODS: PROLONG (PFO Transcatheter Occlusion Long-Term Outcomes National Group) is an investigator-initiated, multicenter, retrospective registry that enrolled patients who underwent transcatheter PFO closure between 1999 and 2013 at 12 centers in Italy. This analysis included only patients who underwent PFO closure for cryptogenic embolism, defined as cryptogenic ischemic stroke, transient ischemic attack, systemic embolism, or silent ischemic lesions on magnetic resonance imaging. Clinical, imaging, procedural, and follow-up data were collected from electronic health records and telephone interviews. RESULTS: The study included 1,245 patients (mean age 47 ± 12 years, 56% women), with a mean follow-up duration of 14.5 ± 2.4 years. During follow-up, 34 patients (2.7%) experienced recurrent ischemic stroke, transient ischemic attack, or systemic embolism (0.19 per 100 patient-years). Predictors of recurrent events were Risk of Paradoxical Embolism (RoPE) score ≤ 7 (HR: 3.44; 95% CI: 1.06-11.3; P = 0.041), nonprobable PFO-Associated Stroke Causal Likelihood (PASCAL) classification (HR: 2.72; 95% CI: 1.17-6.34; P = 0.020), and new-onset atrial fibrillation (HR: 7.01; 95% CI: 2.45-20.1; P < 0.001). Serious complications were rare (0.4% in hospital, 0.4% during follow-up) and nonfatal. CONCLUSIONS: This study confirms the long-term efficacy and safety of transcatheter PFO closure for patients with cryptogenic embolism and PFO in a real-world setting. (PFO Transcatheter Occlusion Long-Term Outcomes National Group [PROLONG] Registry; NCT06504121).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- IRCCS Centro Cardiologico Monzino, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
- Department of Cardiac, Thoracic, Vascular Science and Public Health, University of Padua, Padua, Italy.
- Pediatric Cardiology and Adult Congenital Heart Disease Program, Department of Cardio-Thoracic and Vascular Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
- Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Cardiac Thoracic and Vascular Department, Università Degli Studi di Bologna, Bologna, Italy.
Zitieren
APA
Gaspardone, C., Trabattoni, D., d'Atri, D. O., Morosato, M., Costa, P., Fraccaro, C., Donti, A., Saia, F., Toscano, E., Scalise, F., Cucco, A., Patti, G., Nerla, R., Castriota, F., Trani, C., Improta, R., Mancone, M., Sardella, G., Musto, C., …, & Godino, C. (2025). 15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism. JACC: Cardiovascular Interventions, 18(12), 1526-1537. https://doi.org/10.1016/j.jcin.2025.04.041
Vancouver
Gaspardone C, Trabattoni D, d'Atri DO, Morosato M, Costa P, Fraccaro C, et al. 15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism. JACC: Cardiovascular Interventions. 2025;18(12):1526-1537. doi:10.1016/j.jcin.2025.04.041
BibTeX
@article{Gaspardone2025,
author = {Gaspardone, Carlo and Trabattoni, Daniela and d'Atri, Daniele O and Morosato, Michele and Costa, Paolo and Fraccaro, Chiara and Donti, Andrea and Saia, Francesco and Toscano, Evelina and Scalise, Filippo and Cucco, Alessio and Patti, Giuseppe and Nerla, Roberto and Castriota, Fausto and Trani, Carlo and Improta, Riccardo and Mancone, Massimo and Sardella, Gennaro and Musto, Carmine and Paciaroni, Maurizio and Morciano, Davide A and Ricchetti, Gianluca and Zaccaria, Lorenzo and Beneduce, Alessandro and Barone, Giuseppe and Salerno, Anna and Vella, Ciro S and Montorfano, Matteo and Pappone, Carlo and Colombo, Antonio and Maisano, Francesco and Burzotta, Francesco and Tarantini, Giuseppe and Margonato, Alberto and Gaspardone, Achille and Godino, Cosmo},
title = {15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
volume = {18},
number = {12},
pages = {1526--1537},
doi = {10.1016/j.jcin.2025.04.041}
}
EUVIMED